Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA granted orphan drug exclusivity for JZP258, an oral solution for the treatment of narcolepsy symptoms, according to the agent’s manufacturer. JZP258 (Jazz Pharmaceuticals plc), also known as Xywav, is a low-sodium oxybate aimed at correcting cataplexy and excessive daytime sleepiness in patients aged as young as 7 years, as well as narcolepsy in adults.
Healio Psoriatic Disease | Drug adherence is one of the biggest barriers to topical psoriasis treatment. Messy vehicles, multiple daily applications and cost factors can all impact a patient’s adherence rates. Mathias Tiedemann Svendsen, MD, PhD, specialist in dermato-venereology and clinical assistant for the department of dermatology and allergy center at Odense University Hospital in Denmark, regularly conducts
AffaMed Therapeutics and Hanmi Pharmaceutical have entered into a licensing agreement granting AffaMed exclusive rights to develop and commercialize risuteganib in Greater China, according to a press release.
IOL exchange and the benefits of SMILE procedures dominated refractive surgery news in December.Check out the recent top-performing items focusing on refractive surgery on Healio/OSN.
The American Heart Association Scientific Sessions were held virtually Nov. 13 to 15. The event included numerous presentations of new data in cardiology.Healio spoke with several experts to discuss top takeaways from the meeting, including Sana M. Al-Khatib, MD, MHS, FHRS, from Duke University School of Medicine and Duke Clinical Research Institute; Joanna Chikwe, MD, FRCS, from Smidt Heart